DAA2300 |
chemokine (C-X-C motif) ligand 12 decreases with age |
Molecular |
hippocampus |
Human |
CXCL12 |
30.9% Decrease Gene Expression Level |
|
DAA2352 |
Pannexin 2 decreases with age |
Molecular |
hippocampus |
Human |
PANX2 |
19.1% Decrease Gene Expression Level |
|
DAA2255 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
Molecular |
hippocampus |
Human |
CASP1 |
137.3% Increase Gene Expression Level |
|
DAA2298 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
hippocampus |
Human |
CX3CL1 |
31.6% Decrease Gene Expression Level |
|
DAA2316 |
Major histocompatibility complex, class II, DP alpha 1 increases with age |
Molecular |
hippocampus |
Human |
HLA-DPA1 |
153.2% Increase Gene Expression Level |
|
DAA2359 |
major histocompatibility complex, class II, DR alpha increases with age |
Molecular |
hippocampus |
Human |
HLA-DRA |
324.5% Increase Gene Expression Level |
|
DAA2254 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
Molecular |
hippocampus |
Human |
CASP1 |
91.8% Increase Gene Expression Level |
|
DAA2253 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
Molecular |
hippocampus |
Human |
CASP1 |
102.7% Increase Gene Expression Level |
|
DAA2358 |
major histocompatibility complex, class II, DQ beta 1 increases with age |
Molecular |
hippocampus |
Human |
HLA-DQB1 |
135.4% Increase Gene Expression Level |
|
DAA2207 |
CD14 molecule increases with age |
Molecular |
hippocampus |
Human |
CD14 |
395.0% Increase Gene Expression Level |
|
DAA2251 |
interleukin 18 (interferon-gamma-inducing factor) increases with age |
Molecular |
hippocampus |
Human |
IL18 |
68.9% Increase Gene Expression Level |
|
DAA2373 |
major histocompatibility complex, class I, B increases with age |
Molecular |
hippocampus |
Human |
HLA-B |
44.0% Increase Gene Expression Level |
|
DAA2252 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
Molecular |
hippocampus |
Human |
CASP1 |
101.8% Increase Gene Expression Level |
|
DAA2250 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
Molecular |
hippocampus |
Human |
CASP1 |
165.5% Increase Gene Expression Level |
|
DAA2327 |
major histocompatibility complex, class I, B increases with age |
Molecular |
hippocampus |
Human |
HLA-B |
35.0% Increase Gene Expression Level |
|
DAA2208 |
toll-like receptor 1 increases with age |
Molecular |
hippocampus |
Human |
TLR1 |
87.3% Increase Gene Expression Level |
|
DAA743 |
Sensitivity of HPA axis is impaired |
Physiological |
pituitary gland, adrenal gland, hypothalamus |
Human |
— |
— |
|
DAA1981 |
Selective increase in oxidative damage and decrease in antioxidant function during aging in the substantia nigra |
Physiological |
substantia nigra |
Human |
— |
— |
|
DAA722 |
Accumulation of neuromelanin in dopaminergic nigral neurons |
Physiological |
substantia nigra |
Human |
— |
— |
|
DAA1079 |
Pipecolic Acid Oxidase |
Molecular |
pons |
Human |
PIPOX |
Increase DNA Methylation |
|
DAA1087 |
Rhomboid Domain Containing 1 |
Molecular |
pons |
Human |
RHBDD1 |
Increase DNA Methylation |
|
DAA1107 |
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 |
Molecular |
pons |
Human |
B3GALT6 |
Increase DNA Methylation |
|
DAA1103 |
Myogenic Differentiation 1 |
Molecular |
pons |
Human |
MYOD1 |
Increase DNA Methylation |
|
DAA1095 |
Prostaglandin E Receptor 3 (subtype EP3) |
Molecular |
pons |
Human |
PTGER3 |
Increase DNA Methylation |
|
DAA1115 |
Growth Arrest-specific 2 Like 3 |
Molecular |
pons |
Human |
GAS2L3 |
Increase DNA Methylation |
|